• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Postmarket Drug Safety Information for Patients and Providers

In accordance with Section 915 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), this website contains links to postmarket drug safety information to improve transparency and communication to patients and healthcare providers. 

 

-

Studies and Clinical Trials of Approved Products

-
-

Latest Safety Information

-
-

General Health Information

  • MedlinePlus
    Authoritative drug and health information from the National Institutes of Health (NIH), and other government agencies and health-related organizations.
-
-

Drug Labeling

-
-

Consumer Information

-
-